Chemotherapy response related massive bleeding and management
의약학 > 내과학
( Ha Yeol Park ) , ( Choon Hae Chung ) , ( Chi Young Park ) , ( Sang Gon Park )
대한내과학회 추계학술발표논문집 2011년, 제2011권 제1호, 284(총1쪽)
42846718.pdf [무료 PDF 뷰어 다운로드]
  • ※ 본 자료는 참고용 논문으로 수정 및 텍스트 복사가 되지 않습니다.
  • 구매가격
    30원 (구매자료 3% 적립)
    이메일 발송  스크랩 하기
    자료 다운로드  네이버 로그인
    The goals of palliative chemotherapy are to improve overall survival and the quality of life through relief of symptoms.The other hand, chemotherapy has many side effects such as myelosupression, neuropathy, gastro-intestinal symptom and infertility. In many known side effects of chemotherapy, bleeding occurs in approximately 6-10% of patients with advanced cancer. Most of bleeding is local vessel damage and systemic process such as disseminatated intravascular coagulopathy, abnormalities in platelet function or number after chemotherapy. There is no article about chemotherapy response related bleeding. However, bleeding may occur in chemo-sensitive tumor like lymphoma and in pre radiotherapy patient such as head and neck cancer, rectal cancer after chemotherapy. There are three cases of pure chemotherapy response related bleeding without other bleeding condition. One is pre-radiotherapy given maxillary sinus cancer, another is chemo sensitive gastric cancer and the last case is pre-radiotherapy given rectal cancer. These all cases had a massive bleeding after chemotherapy without other bleeding condition and successful management variable method such as embolization, endoscopy, and thrombotic agent.
    사업자등록번호 220-87-87785 대표.신현웅 주소.서울시 서초구 방배로10길 18, 402호 대표전화.070-8809-9397
    개인정보책임자.박정아 통신판매업신고번호 제2017-서울서초-1765호 이메일
    copyright (c) 2009 happynlife. steel All reserved.